HomeMarketsSharesHUTCHMED China Ltd

Trade HUTCHMED China Ltd - HCM CFD

2.1325+0.47%
The chart shows the HCM stock price data over the last 1 day, with a current price of 2.1325, a high of 2.0975, and a low of 2.0475.
Low: 2.0475High: 2.0975
Sellers:
0%
Buyers:
100%
Past performance is not a reliable indicator of future results. Share prices are indicative and may differ from live market prices.
Trading Conditions
Type
This financial market is available for CFD trading.
Learn more about:CFDs
CFD
Spread0.085
Long position overnight funding adjustment
Long position overnight funding adjustment

Margin. Your investment
£1,000.00
Overnight funding adjustment
Charges from full value of position
-0.021268 %
(-£1.06)

Trade size with leverage ~ £5,000.00

Money from leverage ~ $£4,000.00


-0.02127%
Short position overnight funding adjustment
Short position overnight funding adjustment

Margin. Your investment
£1,000.00
Overnight funding adjustment
Charges from full value of position
-0.00065 %
(-£0.03)

Trade size with leverage ~ £5,000.00

Money from leverage ~ $£4,000.00


-0.00065%
Overnight funding adjustment time21:00 (UTC)
CurrencyGBP
Min traded quantity10
Margin20.00%
Stock exchangeGreat Britain
Commission on trade10%
Guaranteed stop premium
A guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.
1%

1Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information

Key Stats
Prev. Close2.1175
Open2.0975
1-Year Change-9.1%
Day's Range2.0475 - 2.0975

Trade HUTCHMED China Ltd - HCM

HUTCHMED (China) Ltd (LSE: HCM) is a biopharmaceutical company focused on the discovery, development, and commercialisation of targeted therapies and immunotherapies for cancer and autoimmune diseases. With a strong R&D pipeline and operations across China and the US, HUTCHMED is advancing innovative treatments for global markets. Its integrated approach, from research to commercialisation, positions it as a key player in Asia’s growing biotech industry.

User feedback and ratings

Showing our 4 & 5 star reviews. The specific details of the user have been intentionally anonymised to safeguard their privacy pursuant to GDPR requirements.

Ready to join a leading broker?

1. Create your account2. Make your first deposit3. Start when you’re ready